Combined Effect of Hemostatic Gene Polymorphisms and Myocardial Infarction Risk
Author Information
Author(s): Martinelli Nicola, Trabetti Elisabetta, Pinotti Mirko, Olivieri Oliviero, Sandri Marco, Friso Simonetta, Pizzolo Francesca, Bozzini Claudia, Caruso Pier Paolo, Cavallari Ugo, Cheng Suzanne, Pignatti Pier Franco, Bernardi Francesco, Corrocher Roberto, Girelli Domenico
Primary Institution: Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
Hypothesis
The study aims to evaluate the combined effect of ten common prothrombotic polymorphisms as a determinant of myocardial infarction (MI).
Conclusion
The combination of prothrombotic polymorphisms may help to predict MI in patients with advanced coronary artery disease.
Supporting Evidence
- The prevalence of myocardial infarction increased linearly with the number of unfavorable alleles.
- Subjects with ≤2 unfavorable alleles had a decreased risk of myocardial infarction.
- Those with ≥8 unfavorable alleles had an increased risk of myocardial infarction.
Takeaway
This study found that having more bad genes related to blood clotting can increase the risk of having a heart attack.
Methodology
The study analyzed 804 subjects, including 489 with severe coronary artery disease, to assess the impact of ten genetic polymorphisms on MI risk.
Potential Biases
Possible confounding from the survivor effect and oversimplification of the prothrombotic score.
Limitations
The study had a relatively low number of subjects and a retrospective case-control design.
Participant Demographics
The study included 804 subjects, with 489 having severe coronary artery disease and 315 being CAD-free, primarily from Northern Italy.
Statistical Information
P-Value
0.001
Confidence Interval
95% CI 1.06–1.39
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website